# A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam

> **NCT02233972** · PHASE4 · COMPLETED · sponsor: **Jiangsu Kanion Pharmaceutical Co., Ltd** · enrollment: 15 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Ginkgolides Meglumine Injection
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02233972
- **Lead sponsor:** Jiangsu Kanion Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02233972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02233972, "A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02233972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*